Long-term and serious harms of medical cannabis and cannabinoids for chronic pain: a systematic review of non-randomised studies by Arnav Agarwal, Jason W Busse, Rachel Couban, Patrick Hong, Dena Zeraatkar, Thomas Agoritsas, Robin W M Vernooij, Brian Y Hong, Muhammad Muneeb Ahmed, Jared E Dookie, Matthew Adam Cooper, Gareth Leung, Kevin Loniewski, Chris Hong

“…Objective To establish the prevalence of long-term and serious harms of medical cannabis for chronic pain.Design Systematic review and meta-analysis.Data sources MEDLINE, EMBASE, PsycINFO and CENTRAL from inception to 1 April 2020.Study selection Non-randomised studies reporting on harms of medical cannabis or cannabinoids in adults or children living with chronic pain with ≥4 weeks of follow-up.Data extraction and synthesis A parallel guideline panel provided input on the design and interpretation of the systematic review, including selection of adverse events for consideration. …”
Get full text

Availability of medical cannabis services by racial, social, and geographic characteristics of neighborhoods in New York: a cross-sectional study by Chinazo O. Cunningham, Chenshu Zhang, Maegan Hollins, Melinda Wang, Sumeet Singh-Tan, Paul J. Joudrey

Subjects: “…Medical cannabis…”
Get full text

Abstracts - 5th International Medical Cannabis Conference (CannX 2020), Virtual, October 26-28, 2020

“…Medical Cannabis and Cannabinoids…”
Get full text

Medical Cannabis Use by Rheumatology Patients Following Recreational Legalization: A Prospective Observational Study of 1000 Patients in Canada by Mary‐Ann Fitzcharles, Emmanouil Rampakakis, John Sampalis, Yoram Shir, Martin Cohen, Michael Starr, Winfried Häuser

“…With the current recreational legalization, we have reexamined the prevalence and characteristics of medical cannabis use in this same rheumatology setting. …”
Get full text

An observational study of clinical outcome measures in patients treated with cannabis‐based medicinal products on the UK Medical Cannabis Registry by Simon Erridge, Ophilia Leung, Carl Holvey, Ross Coomber, Sushil Beri, Shaheen Khan, Mark W. Weatherall, James J. Rucker, Michael W. Platt, Mikael H. Sodergren

Get full text

Attitudes, beliefs and knowledge about medical cannabis among nurses and midwives in Cyprus: a cross-sectional descriptive correlational study by S. Sokratous, K. Kaikoush, M. D. Mpouzika, G. Alexandrou, N. M. Karanikola

Subjects: Get full text

Non-medical Cannabis Self-Exposure as a Dimensional Predictor of Opioid Dependence Diagnosis: A Propensity Score Matched Analysis by Eduardo R. Butelman, Angelo G. I. Maremmani, Silvia Bacciardi, Carina Y. Chen, Joel Correa da Rosa, Mary Jeanne Kreek

“…Background: The impact of increasing non-medical cannabis use on vulnerability to develop opioid use disorders has received considerable attention, with contrasting findings. …”
Get full text

6th International Medical Cannabis Conference (CannX 2022) Tel Aviv, Israel, March 14-15, 2022

“…Medical Cannabis and Cannabinoids…”
Get full text

Medical cannabis dimethyl ether, ethanol and butane extracts inhibit the in vitro growth of bacteria and dermatophytes causing common skin diseases by Tomáš Skala, Zdeˇnka Kahánková, Jan Tauchen, Anežka Janatová, Pavel Klouˇcek, Vít Hubka, Adéla Fraˇnková

Get full text

A Mapping Literature Review of Medical Cannabis Clinical Outcomes and Quality of Evidence in Approved Conditions in the USA from 2016 to 2019 by Sebastian Jugl, Aimalohi Okpeku, Brianna Costales, Earl J. Morris, Golnoosh Alipour-Haris, Juan M. Hincapie-Castillo, Nichole E. Stetten, Ruba Sajdeya, Shailina Keshwani, Verlin Joseph, Yahan Zhang, Yun Shen, Lauren Adkins, Almut G. Winterstein, Amie Goodin

“…Medical Cannabis and Cannabinoids…”
Get full text

Medical Cannabis Received by Patients According to Qualifying Condition in a US State Cannabis Program: Product Choice, Dosing, and Age-Related Trends by Xintian Lyu, BS, Sílvia M. Illamola, PharmD, PhD, Susan E. Marino, PhD, Ilo E. Leppik, MD, Stephen Dahmer, MD, Paloma Lehfeldt, MD, Jeannine M. Conway, PharmD, Rory P. Remmel, PhD, Kyle Kingsley, MD, Angela K. Birnbaum, PhD

Subjects: Get full text

Can Prescribed Cannabinoids Substitute Cannabis? by A. Batalla

Subjects: “…medical cannabis…”
Get full text

Elicitation of stakeholder viewpoints about medical cannabis research for pain management in critically ill ventilated patients: A Q-methodology study. by Giulio DiDiodato, Samah Hassan, Kieran Cooley

“…<h4>Objectives</h4>To determine acceptability of medical cannabis research in critically ill patients.<h4>Design</h4>Q-methodology survey.…”
Get full text

Medical Cannabis Alleviates Chronic Neuropathic Pain Effectively and Sustainably without Severe Adverse Effect: A Retrospective Study on 99 Cases by Lan Kluwe, Christian Scholze, Lisa Marie Schmidberg, Julian Lukas Wichmann, Mihail Gemkov, Martin Julian Keller, Said C. Farschtschi

Subjects: Get full text

‘What price do you put on your health?’: Medical cannabis, financial toxicity and patient perspectives on medication access in advanced cancer by Rebecca E. Olson, Alexandra Smith, Phillip Good, Morgan Dudley, Taylan Gurgenci, Janet Hardy

Get full text

Too Dense or Not Too Dense: Higher Planting Density Reduces Cannabinoid Uniformity but Increases Yield/Area in Drug-Type Medical Cannabis by Nadav Danziger, Nirit Bernstein

“…This study revealed the importance of plant density and architecture for chemical quality and standardization in drug-type medical cannabis.…”
Get full text

Feasibility and acceptability of using smartphone-based EMA to assess patterns of prescription opioid and medical cannabis use among individuals with chronic pain by Erin M. Anderson Goodell, Courtney Nordeck, Patrick H. Finan, Ryan Vandrey, Kelly E. Dunn, Johannes Thrul

“…Participants also mentioned problems with reporting the amount of medical cannabis used (e.g., milliliters of vaping liquid). …”
Get full text

Attitudes, beliefs, and knowledge regarding medical cannabis among healthcare students in the Republic of Cyprus: a cross-sectional descriptive correlational study by Sokratis Sokratous, Meropi Mpouzika, Katerina Kaikoushi, George Alexandrou, Maria Karanikola

Subjects: Get full text

Adverse outcomes of cannabis use in Canada, before and after legalisation of non-medical cannabis: cross-sectional analysis of the International Cannabis Policy Study by David Hammond, Anastasia Marquette, Maryam Iraniparast

“…The current study examined trends in the prevalence of adverse events among people who consumed cannabis before and after Canada’s legalisation of recreational cannabis.Design Data come from the first four survey waves of the International Cannabis Policy Study, which were conducted online annually immediately prior to non-medical cannabis legalisation in Canada in October 2018, and in the three following years (2019–2021).Participants The current analysis included 18 285 Canadian respondents aged 16–65 who reported cannabis use in the past 12 months.Outcome measures Primary outcomes included types of adverse events experienced from cannabis use, medical help-seeking and the types of products used. …”
Get full text

Available but inaccessible: patient experiences during the first 2 years of a primary care-based medical cannabis program at an academic medical center by Eloise W. Freitag, Yuval Zolotov, Jayabhargav Annam, Jaqueline Labins, Jaclyn M. Yamada, Syeda Masharab Jillani, Julia H. Arnsten, Deepika E. Slawek

Subjects: “…Medical cannabis…”
Get full text